| New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies E Larrea, C Sole, L Manterola, I Goicoechea, M Armesto, M Arestin, ... International journal of molecular sciences 17 (5), 627, 2016 | 282 | 2016 |
| Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard-and high-risk myeloma I Goicoechea, N Puig, MT Cedena, L Burgos, L Cordón, MB Vidriales, ... Blood, The Journal of the American Society of Hematology 137 (1), 49-60, 2021 | 116 | 2021 |
| Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma C Perez, C Botta, A Zabaleta, N Puig, MT Cedena, I Goicoechea, ... Blood, The Journal of the American Society of Hematology 136 (2), 199-209, 2020 | 109 | 2020 |
| The circulating transcriptome as a source of non‐invasive cancer biomarkers: concepts and controversies of non‐coding and coding RNA in body fluids M Fernandez‐Mercado, L Manterola, E Larrea, I Goicoechea, M Arestin, ... Journal of cellular and molecular medicine 19 (10), 2307-2323, 2015 | 97 | 2015 |
| Targeted next‐generation sequencing and non‐coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other … CH Lawrie, E Larrea, G Larrinaga, I Goicoechea, M Arestin, ... The Journal of Pathology 232 (1), 32-42, 2014 | 64 | 2014 |
| Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination JJ Garcés, M Simicek, M Vicari, L Brozova, L Burgos, R Bezdekova, ... Leukemia 34 (2), 589-603, 2020 | 59 | 2020 |
| MGMT expression predicts PARP-mediated resistance to temozolomide O Erice, MP Smith, R White, I Goicoechea, J Barriuso, C Jones, ... Molecular cancer therapeutics 14 (5), 1236-1246, 2015 | 53 | 2015 |
| The circulating transcriptome as a source of biomarkers for melanoma C Solé, D Tramonti, M Schramm, I Goicoechea, M Armesto, LI Hernandez, ... Cancers 11 (1), 70, 2019 | 47 | 2019 |
| Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma M Larrayoz, MJ Garcia-Barchino, J Celay, A Etxebeste, M Jimenez, ... Nature Medicine 29 (3), 632-645, 2023 | 45 | 2023 |
| Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma C Maia, N Puig, MT Cedena, I Goicoechea, R Valdes-Mas, I Vazquez, ... Blood, The Journal of the American Society of Hematology 135 (26), 2375-2387, 2020 | 40 | 2020 |
| Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma JJ Garcés, G Bretones, L Burgos, R Valdes-Mas, N Puig, MT Cedena, ... Leukemia 34 (11), 3007-3018, 2020 | 34 | 2020 |
| Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma L Manterola, P Aguirre, E Larrea, M Arestín, A Gaafar, K Elorriaga, ... Scientific Reports 8 (1), 6613, 2018 | 32 | 2018 |
| Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma S Rodriguez, J Celay, I Goicoechea, C Jimenez, C Botta, ... Science Advances 8 (3), eabl4644, 2022 | 29 | 2022 |
| A machine learning model based on tumor and immune biomarkers to predict undetectable MRD and survival outcomes in multiple myeloma C Guerrero, N Puig, MT Cedena, I Goicoechea, C Perez, JJ Garcés, ... Clinical Cancer Research 28 (12), 2598-2609, 2022 | 27 | 2022 |
| An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis A Nevone, M Girelli, S Mangiacavalli, B Paiva, P Milani, P Cascino, ... Leukemia 36 (8), 2076-2085, 2022 | 26 | 2022 |
| Noncoding RNA expression and targeted next-generation sequencing distinguish tubulocystic renal cell carcinoma (TC-RCC) from other renal neoplasms CH Lawrie, M Armesto, M Fernandez-Mercado, M Arestín, L Manterola, ... The Journal of Molecular Diagnostics 20 (1), 34-45, 2018 | 26 | 2018 |
| Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development D Alameda, I Goicoechea, M Vicari, E Arriazu, A Nevone, S Rodriguez, ... Blood, The Journal of the American Society of Hematology 138 (17), 1583-1589, 2021 | 23 | 2021 |
| The urinary transcriptome as a source of biomarkers for prostate cancer C Solé, I Goicoechea, A Goñi, M Schramm, M Armesto, M Arestin, ... Cancers 12 (2), 513, 2020 | 20 | 2020 |
| Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer R Argnani, P Marconi, I Volpi, E Bolanos, E Carro, C Ried, E Santamaria, ... Liver International 31 (10), 1542-1553, 2011 | 15 | 2011 |
| Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance C Botta, C Perez, M Larrayoz, N Puig, MT Cedena, R Termini, ... Nature communications 14 (1), 5825, 2023 | 13 | 2023 |
charles lawrieBiodonostia. Research InstituteVerified email at ndcls.ox.ac.uk
